Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-15005846Phase 4Recruiting
Phase 4, open-label trial of cinobufotalin in colorectal cancer (CRC) (2 arms), sponsored by Central Hospital of Shanghai Putuo District. Primary endpoints: Routine blood test, Urine routine test and 7 more. Started Oct 2014; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-15005846.